jeanette josefina peña | Universidad Arturo Michelena (original) (raw)
Uploads
Papers by jeanette josefina peña
Espiral (Guadalajara), Apr 1, 2010
Espiral Estudios sobre Estado y sociedad, 2010
Proyecto académico sin fines de lucro, desarrollado bajo la iniciativa de acceso abierto
Anales españoles de pediatría, 1980
Appearance of dystonic movements in four epileptics children, while carbamazepine administration,... more Appearance of dystonic movements in four epileptics children, while carbamazepine administration, is the object of this publication. Human material is formed by four patients in pediatric ages of 4.5, 5, 6 and 7 years old, which presented dystonia after the administration of carbamazepine. Clinical, neuroradiological, psychometric and bioelectric explorations were performed, also serum determinations of anticonvulsant levels. Three of the children presented serious psychomotor retardation. The electroencephalograms showed no uniform changes. Serum levels of carbamazepine were in therapeutics limits. From this personal experience and bibliography data it is deduced that dystonia is not a toxic phenomena, establishing the possibility of an interaction between carbamazepine and dopaminergic system.
Journal for Specialists in Pediatric Nursing, 2003
We conducted a retrospective study of the case files of 64 multiple sclerosis (MS) patients prese... more We conducted a retrospective study of the case files of 64 multiple sclerosis (MS) patients presenting severe spasticity, who had received intrathecal (IT) baclofen test injections between 1992 and 2004 in a rehabilitation unit. In almost all cases of our series, IT baclofen was proposed to patients who were no longer able to walk. IT baclofen is a safe and effective treatment to reduce spasticity in MS patients. Despite an advanced stage of the disease at the time of pump placement, the complication rate was low and the efficacy of this treatment was maintained over time. Multiple Sclerosis 2006; 12: 101 Á/103. www.multiplesclerosisjournal.com
Espiral (Guadalajara), Apr 1, 2010
Espiral Estudios sobre Estado y sociedad, 2010
Proyecto académico sin fines de lucro, desarrollado bajo la iniciativa de acceso abierto
Anales españoles de pediatría, 1980
Appearance of dystonic movements in four epileptics children, while carbamazepine administration,... more Appearance of dystonic movements in four epileptics children, while carbamazepine administration, is the object of this publication. Human material is formed by four patients in pediatric ages of 4.5, 5, 6 and 7 years old, which presented dystonia after the administration of carbamazepine. Clinical, neuroradiological, psychometric and bioelectric explorations were performed, also serum determinations of anticonvulsant levels. Three of the children presented serious psychomotor retardation. The electroencephalograms showed no uniform changes. Serum levels of carbamazepine were in therapeutics limits. From this personal experience and bibliography data it is deduced that dystonia is not a toxic phenomena, establishing the possibility of an interaction between carbamazepine and dopaminergic system.
Journal for Specialists in Pediatric Nursing, 2003
We conducted a retrospective study of the case files of 64 multiple sclerosis (MS) patients prese... more We conducted a retrospective study of the case files of 64 multiple sclerosis (MS) patients presenting severe spasticity, who had received intrathecal (IT) baclofen test injections between 1992 and 2004 in a rehabilitation unit. In almost all cases of our series, IT baclofen was proposed to patients who were no longer able to walk. IT baclofen is a safe and effective treatment to reduce spasticity in MS patients. Despite an advanced stage of the disease at the time of pump placement, the complication rate was low and the efficacy of this treatment was maintained over time. Multiple Sclerosis 2006; 12: 101 Á/103. www.multiplesclerosisjournal.com